CD BIOSCIENCES INC

CD Biosciences Inc. specializes in advanced genomic sequencing and molecular diagnostics services, with deep expertise in next-generation sequencing technologies including shotgun metagenomics, RNA-seq, TCR sequencing, and HPV genotyping. The company delivers high-precision analytical services for complex biological samples, supporting research and public health initiatives through rigorous DNA and RNA quality control, pathogen identification, and microbial community profiling. Their technical capabilities span end-to-end sample processing, bioinformatic analysis, and data interpretation for infectious disease surveillance, immunological research, and agricultural pathogen monitoring, positioning them as a trusted provider of laboratory-grade genomic insights for mission-critical government programs. The contractor maintains a strong, sustained relationship with the Department of Health and Human Services, consistently delivering sequencing and diagnostic services for public health surveillance, infectious disease characterization, and genomic quality assurance. They also support the Department of Agriculture with biotechnological research initiatives focused on insect genomics and RNA sequencing, demonstrating adaptability across human health and agricultural bioscience domains. Their work reflects a pattern of repeat engagement on specialized, technically demanding projects requiring high accuracy and regulatory compliance. CD Biosciences operates primarily within the testing laboratories and biotechnology R&D sectors, with core focus on genomic analysis services that bridge clinical, environmental, and agricultural applications. Their market positioning centers on niche, high-complexity sequencing workflows that demand specialized instrumentation, validated protocols, and bioinformatics expertise—differentiating them from generalist labs. They serve as a technical partner for agencies requiring actionable genomic data from low-abundance or degraded samples. As a small business structured as a 2L entity based in Shirley, New York, CD Biosciences Inc. is positioned to support federal science and health missions with agility and technical precision. While no formal government certifications are listed, their consistent award history reflects proven capability in delivering compliant, high-quality genomic services to federal stakeholders.